27 completed. 27 Phase 1, 11 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 27 | Completed 27 |
| Phase 2 | 11 | Completed 11 |
Follow Social Behavior: new trials by email Literature Review of Social Behavior trials Research Report on Social Behavior
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Result of tDCS in ASD Children With Comorbidities Like PANDAS, Rare Genetic Diseases or Autoimmune Disorders tDCS or Transcranial Direct Current Stimulation, Risperidone, Sham tDCS - Attention, Visual Perceptual Weakness | Phase 1 / Phase 2 | Completed | Spanish Foundation for Neurometrics Development | 180 | 2024-04-01 | 2026-09-10 |
| PRISM Race and Communication Pilot RCT Promoting Resilience in Stress Management (PRISM) - Discrimination, Racial, Communication | Phase 1 / Phase 2 | Completed | University of Washington | 28 | 2023-07-19 | 2026-04-30 |
| Arthritis Ease Study Virtual Reality Nature scene plus heart rate variability biofeedback phone application - Knee Osteoarthritis, Chronic Pain | Phase 1 / Phase 2 | Completed | Arizona State University | 36 | 2022-09-15 | 2024-09-23 |
| Clinical Trial of Nabilone for Aggression in Adults With Intellectual and Developmental Disabilities Nabilone - Intellectual Disability, Developmental Disability | Phase 1 | Completed | Hsiang-Yuan Lin | 20 | 2022-03-17 | 2026-01-23 |
| Daratumumab-SC for Highly Sensitized Patients Awaiting Heart Transplantation Daratumumab-SC - Allosensitization, Heart Transplant Failure and Rejection | Phase 1 | Completed | Ronald Witteles | 8 | 2021-07-01 | 2024-03-25 |
| Task-Based Grounding Program Task-Based Grounding, Connected Care (Enhanced Treatment as usual) - Aggressive, Defiant Disorder, Oppositional | Phase 1 | Completed | Dartmouth-Hitchcock Medical Center | 28 | 2020-12-03 | 2021-11-08 |
| Comparison of the Cognitive and Motor Effects of Treatment Between an Immediate- and Extended-release Tacrolimus (Envarsus® XR) Based Immunosuppression Regimen in Kidney Transplant Recipients immediate-release tacrolimus, extended release tacrolimus - Kidney Transplant Failure and Rejection | Phase 1 / Phase 2 | Completed | University of Minnesota | 18 | 2018-05-08 | 2021-04-15 |
| Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant Clazakizumab - Kidney Failure, Chronic, End-Stage Renal Disease | Phase 1 / Phase 2 | Completed | Stanley Jordan, MD | 20 | 2018-02-27 | 2026-10-30 |
| KPT-330 Plus RICE for Relapsed/Refractory Aggressive B-Cell Lymphoma KPT-330, Rituximab, Etoposide - Diffuse Large B-Cell Lymphoma | Phase 1 | Completed | Weill Medical College of Cornell University | 22 | 2015-12-11 | 2022-04-12 |
| Nicotinic Cholinergic Modulation as a Novel Treatment Strategy for Aggression Associated With Autism Transdermal nicotine, Transdermal placebo - Autism Spectrum Disorder, Aggression | Phase 1 | Completed | Yale University | 8 | 2015-09-01 | 2022-05-06 |
| The StepSmart Project: A Pedometer Based Phased Intervention to Encourage Physical Activity in Schools The StepSmart Challenge - Physical Activity, Health Behavior | Phase 1 | Completed | Queen's University, Belfast | 240 | 2015-04-01 | 2017-08-17 |
| Allogeneic Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients mesenchymal stromal cells - Rejection, Graft Loss | Phase 1 | Completed | Leiden University Medical Center | 10 | 2015-03-01 | 2019-07-02 |
| Differences in Schizophrenia With One-month and 3-month Paliperidone Palmitate Treatment Paliperidone Palmitate 156 MG/ML Prefilled Syringe [Invega], Paliperidone Palmitate 546 MG Intramuscular Suspension, Extended Release [INVEGA TRINZA] - Schizophrenics | Phase 1 / Phase 2 | Completed | Calo Psychiatric Center | 72 | 2015-01-01 | 2021-02-15 |
| Curriculum Evaluation of a Novel Health and Wellness Program Within New York City Schools Yoga-informed Health and Wellness Program, Physical Education Class - Adolescent Behavior | Phase 1 | Completed | Long Island University | 112 | 2014-09-01 | 2016-11-04 |
| Safety, Tolerability and Activity of SRX246 in Adults With Intermittent Explosive Disorder SRX246, Placebo - Intermittent Explosive Disorder | Phase 1 / Phase 2 | Completed | Azevan Pharmaceuticals | 97 | 2014-05-01 | 2023-07-21 |
| Effects of Intranasal Oxytocin on Emotion Regulation in Adolescents Oxytocin, Placebo - Emotion, Parent-Child Relations | Phase 1 | Completed | Centre Hospitalier Universitaire de Besancon | 29 | 2014-04-29 | 2017-12-18 |
| Online Emotional Regulation Group Treatment Online Emotional Regulation Treatment - Traumatic Brain Injury, Executive Dysfunction | Phase 1 | Completed | Icahn School of Medicine at Mount Sinai | 147 | 2012-11-01 | 2015-10-02 |
| Oxytocin Treatment of Social Cognitive and Functional Deficits in Schizophrenia Intranasal Oxytocin Spray - Schizophrenia, Schizoaffective Disorder | Phase 1 | Completed | University of North Carolina, Chapel Hill | 68 | 2011-07-01 | 2015-06-11 |
| Reducing Aggression in Children and Adolescent on an Inpatient Unit ACT with RAGE-Control - Anger, Aggression | Phase 1 | Completed | Gonzalez-Heydrich, Joseph, M.D. | 20 | 2010-06-01 | 2012-03-12 |
| Eliciting Affect in Teens in a Virtual World (Project AVATAR) Virtual Reality, Health Promotion - HIV Infections | Phase 1 / Phase 2 | Completed | Rhode Island Hospital | 196 | 2010-05-01 | 2016-04-06 |
Showing 20 of 27. Sign in to see all of them.
Aggression (7) · Rejection, Psychology (6) · Self-Control (4) · Emotional Regulation (3) · Social Adjustment (3) · Stress Disorders, Post-Traumatic (2) · Adolescent Behavior (1) · Attention Deficit Disorder with Hyperactivity (1) · Autism Spectrum Disorder (1) · Autistic Disorder (1) · Brain Injuries, Traumatic (1) · Bulimia (1) · Chronic Disease (1) · Chronic Pain (1) · Combat Disorders (1)
Behavior (27) · Mental Disorders (9) · Behavioral Symptoms (8) · Aberrant Motor Behavior in Dementia (7) · Pathological Conditions, Signs and Symptoms (5) · Neurodevelopmental Disorders (3) · Signs and Symptoms (3) · Disease Attributes (2) · Immune System Diseases (2) · Nervous System Diseases (2) · Neurologic Manifestations (2) · Nutritional and Metabolic Diseases (2) · Pathologic Processes (2) · Self-Control (2)
Health Promotion (2) · sotrastaurin (2) · Capsules (1) · Carboplatin (1) · Cognitive Behavioral Therapy (1) · Dexamethasone (1) · Diet (1) · Etoposide (1) · Ifosfamide (1) · Interpersonal Psychotherapy (1) · Mycophenolic Acid (1) · Oxytocin (1) · Paliperidone Palmitate (1) · Risperidone (1) · Rituximab (1)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2) · Novartis Pharmaceuticals (2) · Arizona State University (1) · Azevan Pharmaceuticals (1) · Calo Psychiatric Center (1) · Centre Hospitalier Universitaire de Besancon (1) · Dartmouth-Hitchcock Medical Center (1) · Gonzalez-Heydrich, Joseph, M.D. (1) · Hsiang-Yuan Lin (1) · Icahn School of Medicine at Mount Sinai (1) · Leiden University Medical Center (1) · Long Island University (1) · Prevail Health Solutions, LLC (1) · Queen's University, Belfast (1) · Rhode Island Hospital (1)
United States (22) · Canada (3) · France (2) · Germany (2) · Spain (2) · United Kingdom (2) · Belgium (1) · Italy (1) · Netherlands (1) · Sweden (1) · Switzerland (1)
Alan S Lewis, MD, PhD (1) · Benjamin VanVoorhees, MD, MPH (1) · Brock K Hokenson, MBA (1) · Cort A Pedersen, MD (1) · Crystal E Brown, MD, MA (1) · David L Penn, PhD (1) · Dawn M. Johnson, PhD (1) · Elizabeth Wharff, PhD (1) · For-Wey Lung, MD, ScD (1) · Hsiang-Yuan Lin, MD (1) · Jack A Yanovski, M.D. (1) · James T Craig, Ph.D. (1) · Lauriane Vulliez-Coady, PhD (1) · Linda Larkey, PhD (1)
PMID 21564523, PMID 25468234, PMID 26002873, PMID 26210388, PMID 26537851, PMID 27173384, PMID 27459503, PMID 28714097, PMID 29169378, PMID 29625151, PMID 29678971, PMID 31832227, PMID 33578648, PMID 33658971, PMID 33823927, PMID 35734582, PMID 36931838, PMID 37322595, PMID 37445385, PMID 37811711, PMID 38271099
K23MD015270 (1), R01DA017295 (1), R01MH093529 (1), R34MH080786 (1), R42MH087322 (1)